Champions Oncology
CSBR
CSBR
23 hedge funds and large institutions have $31.5M invested in Champions Oncology in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
21% less funds holding
Funds holding: 29 → 23 (-6)
51% less call options, than puts
Call options by funds: $69K | Put options by funds: $141K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Holders
23
Holding in Top 10
1
Calls
$69K
Puts
$141K
Top Buyers
| 1 | +$108K | |
| 2 | +$79.6K | |
| 3 | +$78.1K | |
| 4 |
Morgan Stanley
New York
|
+$39.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$20K |
Top Sellers
| 1 | -$301K | |
| 2 | -$208K | |
| 3 | -$174K | |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$158K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$64.8K |